Mean Kinetic Temperature and Peptide Thermal Excursions: The History a COA Cannot Record

Mean kinetic temperature is the single calculated temperature that reproduces the cumulative chemical damage a fluctuating temperature history would cause, and it is the measurement that tells you whether a peptide thermal excursion mattered. An arithmetic average of transit temperatures systematically understates degradation, because reaction rates rise exponentially with temperature while an average treats them as linear. A certificate of analysis records purity at the moment of assay in the testing laboratory, so nothing on that certificate describes what happened to the vial afterwards.

This is a gap that almost no one in the research peptide market talks about. Laboratories have learned to scrutinise chromatograms, to ask which analytical method produced a purity figure, and to check whether a certificate is batch specific. Far fewer ask the adjacent question, which is what thermal history the material accumulated between the analytical balance and the receiving freezer. That history is measurable, the framework for evaluating it has existed since 1971, and it is almost never disclosed.

What mean kinetic temperature actually measures

The concept originates with J. D. Haynes, who published “Worldwide virtual temperatures for product stability testing” in the Journal of Pharmaceutical Sciences in 1971, volume 60, issue 6, pages 927 to 929. Haynes was solving a specific problem. Products distributed across climates experience wildly different temperature profiles, and stability programmes needed a single number that could stand in for a variable history without discarding the physics.

The solution rests on the Arrhenius relationship. Reaction rate scales with the exponential of the negative activation energy divided by the product of the gas constant and absolute temperature. Because the relationship is exponential rather than linear, a short period at an elevated temperature contributes disproportionately more chemical damage than an equal period at a cool temperature removes. Averaging temperatures arithmetically discards exactly that asymmetry.

Mean kinetic temperature repairs the error by averaging in rate space rather than in temperature space. Each recorded temperature is converted into a relative rate, the rates are averaged, and the result is converted back into a temperature. The output is always equal to or higher than the arithmetic mean of the same data, and the divergence widens as the temperature record becomes more volatile. A shipment that sat at a stable eight degrees Celsius and a shipment that oscillated between two and fourteen degrees can share an arithmetic mean and carry meaningfully different mean kinetic temperatures.

United States Pharmacopeia General Chapter 1079.2 formalises the calculation for evaluating temperature excursions during storage and transportation. It sets a default heat of activation of 83.144 kilojoules per mole unless experimental data supply a better figure for the specific material. That default is a convention, not a measurement, and it is the first place the framework can mislead. A peptide whose dominant degradation pathway has an activation energy materially different from 83.144 kilojoules per mole will have its excursion risk misestimated by a calculation that assumes the default.

Why a purity certificate is a snapshot rather than a warranty

A certificate of analysis characterises material at one moment under the conditions of one laboratory. It is evidence about the past state of a batch. It is not a property of the vial in your hand, and it makes no claim about the interval between assay and receipt. That interval includes weighing, filling, closure, packaging, warehousing, carrier handling, customs holds where applicable, and final delivery. Each of those steps has a temperature profile, and none of them appear on the certificate.

The same structural limitation applies to other attributes that act after the assay. We have written about how light exposure degrades peptides after certification and about how container closure integrity is never addressed by a purity figure. Thermal history belongs in the same category. The certificate is upstream of all of it.

This matters more for peptides than for small molecules because peptide degradation pathways are numerous, several of them are spontaneous, and several produce species that are difficult to resolve chromatographically from the parent compound. A degradation product that co-elutes will not reduce the reported area percent purity even though the material has changed. That is a separate problem from thermal history, and we have covered it in our discussion of what a purity number does and does not report, but the two compound each other. A thermal excursion can generate exactly the class of impurity that a purity assay is least equipped to see.

The chemistry that runs during a thermal excursion

Deamidation is the clock that never stops

Asparagine and glutamine residues deamidate spontaneously in aqueous environments, and the rate depends heavily on the neighbouring sequence. Noah Robinson and Arthur Robinson quantified this systematically in the Proceedings of the National Academy of Sciences in 2001, volume 98, issue 3, pages 944 to 949. Working with 306 asparaginyl sequences in model peptides at pH 7.4, 37.0 degrees Celsius, in 0.15 molar Tris hydrochloride buffer, they measured first order deamidation half times spanning from one day to 455 days.

That is a range of more than two orders of magnitude driven purely by sequence context. The residue on the carboxyl side of the asparagine exerted a larger influence than the residue on the amino side. For all eighteen peptides carrying a carboxyl side proline, half times exceeded 1000 days. The authors proposed that these residues function as programmable molecular clocks timing biological processes, which is an elegant framing with an uncomfortable corollary for anyone shipping peptides. Two compounds of identical purity can have deamidation susceptibilities that differ by a factor of several hundred, and no certificate discloses which one you have.

Solid state is protective, not inert

Lyophilised material is far more stable than material in solution, which is why research peptides ship as dry powder. That stability is relative rather than absolute. Lai and Topp reviewed solid state chemical stability of proteins and peptides in the Journal of Pharmaceutical Sciences in 1999, volume 88, issue 5, pages 489 to 500, establishing that the same degradation chemistries operate in the amorphous solid, only slower and with different rate limiting factors. Ohtake, Feng and Shalaev extended this specifically to deamidation in amorphous pharmaceuticals in the Journal of Pharmaceutical Sciences in 2018, volume 107, pages 42 to 56, examining how residual water governs the reaction in the solid state.

Recent work has put precise numbers on the conformational side of thermal stress. Malayandi and colleagues published a solid state thermal stability study of semaglutide in Pharmaceutical Research in 2026, volume 43, issue 5, pages 1579 to 1597. Using infrared spectroscopy, circular dichroism, differential scanning calorimetry and hot stage microscopy alongside chromatography and high resolution mass spectrometry, they found the compound retained its native alpha helical conformation up to 60 degrees Celsius. Alpha helical content fell from 49.07 percent to 43.75 percent at 60 degrees Celsius, then collapsed to 0.2 percent at 80 degrees Celsius. Modulated differential scanning calorimetry established a glass transition temperature of 169 degrees Celsius, and the material remained amorphous across all tested conditions.

Two conclusions follow. The first is that meaningful conformational change begins well below the glass transition, so glass transition temperature alone is a poor predictor of whether a thermal event mattered. The second is that a purity assay measuring chemical composition can register a compound as intact while its secondary structure has partially unfolded, because chromatographic retention and molecular mass are not sensitive to helicity. Structural integrity and chemical purity are separate attributes, and only one of them appears on a typical certificate.

Key Research Findings

• Haynes, Journal of Pharmaceutical Sciences, 1971, 60(6), 927 to 929, introduced mean kinetic temperature as a single virtual temperature reproducing the cumulative thermal effect of a variable history, derived from Arrhenius kinetics.
• USP General Chapter 1079.2 specifies a default heat of activation of 83.144 kilojoules per mole for mean kinetic temperature calculation, to be replaced by experimental values where available.
• Robinson and Robinson, PNAS, 2001, 98(3), 944 to 949, measured first order deamidation half times of 1 to 455 days across 306 asparaginyl model peptides at pH 7.4 and 37.0 degrees Celsius in 0.15 M Tris hydrochloride.
• In the same dataset, all 18 peptides with a carboxyl side proline showed deamidation half times exceeding 1000 days, confirming sequence context as the dominant rate determinant.
• Malayandi et al., Pharmaceutical Research, 2026, 43(5), 1579 to 1597, reported semaglutide alpha helical content declining from 49.07 percent to 43.75 percent at 60 degrees Celsius and to 0.2 percent at 80 degrees Celsius, with a glass transition temperature of 169 degrees Celsius by modulated DSC.
• Lai and Topp, Journal of Pharmaceutical Sciences, 1999, 88(5), 489 to 500, established that peptide degradation chemistries persist in the amorphous solid state at reduced rates rather than being arrested by lyophilisation.
• Ohtake, Feng and Shalaev, Journal of Pharmaceutical Sciences, 2018, 107, 42 to 56, characterised residual water as a governing variable for deamidation kinetics in amorphous solids.

What the guidance documents actually require

World Health Organization Technical Report Series No. 961, 2011, Annex 9 sets out model guidance for the storage and transport of time and temperature sensitive pharmaceutical products. Its central requirement is not a specific temperature. It is that a transport route be profiled and qualified, meaning that the actual thermal profile of the lane is measured and shown to fall inside a defined envelope, rather than assumed. Technical supplements published in Technical Report Series No. 992, 2015, Annex 5 extend this to temperature mapping of storage areas and to transport operations.

The distinction between profiling and assuming is the whole argument. A supplier claiming that shipments are temperature controlled is making an assertion about intent. A supplier that has profiled its lanes and can produce mean kinetic temperature figures for them is making an assertion about measurement. Those are different claims, and only the second is falsifiable.

It is worth being direct about the limits of this framework in a research supply context. Route qualification is expensive, it is designed for regulated distribution of finished pharmaceuticals, and very few suppliers in this category perform it. Claiming otherwise would be marketing rather than science. The useful version of the standard for a research buyer is narrower, which is that shorter and simpler transit lanes have less accumulated thermal exposure and fewer handoffs at which an excursion can occur. That is a structural argument about geography, not a substitute for measurement.

What this means when evaluating a peptide supplier

The practical questions are narrow and answerable. Whether the supplier can state the physical form as shipped, since lyophilised powder and solution have entirely different thermal vulnerability. Whether transit is domestic or crosses a border, because each additional handoff and each customs hold extends the interval during which temperature is uncontrolled. Whether any temperature monitoring accompanies shipments, and if so whether the record is retained and available. Whether the certificate of analysis is batch specific and carries an assay date, so the interval between assay and receipt is at least calculable.

That last point deserves emphasis. An undated certificate, or one recycled across batches, makes thermal history unknowable in principle rather than merely unmeasured. Maple Research Labs publishes third party analytical documentation on its certificates of analysis page, and compounds in the catalogue such as retatrutide ship as lyophilised powder from a Canadian facility, which shortens the transit interval relative to cross border procurement. We are equally explicit that domestic shipping shortens exposure rather than eliminating it, and that we do not currently publish lane qualification data.

The broader point stands independent of any supplier. Mean kinetic temperature is a well established calculation with a defined standard behind it, peptide degradation chemistry is measured and published, and the interval between certification and receipt is the least documented segment of the entire chain. A research laboratory that treats a purity figure as a permanent property of a vial is making an assumption that the underlying analytical chemistry does not support.

For research purposes only. Not for human consumption. Not for diagnostic or therapeutic use.